
Clene Nanomedicine
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.
Market cap
$54.1m
Enterprise value
$68m
Share price
$5.41 CLNN
Authorizing premium user...
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.